Home  > 
  Novartis announces positivedata from phase IV MS-MRIUS study on Gilenya,   April 25, 2017
  Agenus initiates phase 1/2 trial of anti-PD-1 antibody, AGEN2034,   April 24, 2017
  MGC Diagnostics collaborates with Restech to evaluate diagnostic accuracy of FOT to detect lung function abnormalities,   April 24, 2017
  First patients at VUMC implanted in EndoStim’s LESS GERD clinical trial for GERD,   April 22, 2017
  Prima BioMed receives Australian nod to begin third cohort phase I trial of IMP321 in combo with Keytruda to treat metastatic melanoma,   April 22, 2017
  Lilly to present phase 2 safety data of galcanezumab in patients with migraine at AAN annual meeting,   April 22, 2017
  Allergan, Target PharmaSolutions partner to advance TARGET-NASH study,   April 22, 2017
  ThromboGenics achieves important milestone in development of plasma kallikrein inhibitor, THR-149 to treat DME,   April 21, 2017
  NIH study shows Novartis drug eltrombopag as first-line therapy with standard treatment improves responses in SAA,   April 21, 2017
  Roche to present new data on Ocrevus in people with RMS &PPMS at 69th AAN annual meeting,   April 20, 2017
  Protalix announces positive results from phase II trial of alidornase alfa to treat cystic fibrosis,   April 19, 2017
  Medicenna begins phase 2b recurrent glioblastoma trial,   April 18, 2017
  Allergan collaborates with Novartis to conduct clinical trial to treat NASH,   April 18, 2017
  CASI Pharma stops further patient enrollment in phase 2 study of ENMD-2076 in triple-negative breast cancer,   April 18, 2017
  Roche reports positive interim results for emicizumab in phase III HAVEN 2 study of children with haemophilia A,   April 18, 2017
  Transgene, Institut Bergonié begin phase 2 clinical trial of METROmaJX,   April 17, 2017
  NIH-funded preclinical studies suggest designer drug may treat ALS, spinocerebellar ataxia 2,   April 15, 2017
  AOBiome completes patient enrollment in phase 2 trial of B244 to treat elevated blood pressure,   April 15, 2017
  Novan announces positive results for phase 2clinical trial with SB208 to treat T. Rubrum infection,   April 15, 2017
  Medix receives Mexican regulatory nod to begin phase 3 study of tesofensine in obese patients,   April 14, 2017

Copyright © 2016 Saffron Media Pvt. Ltd |